Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
Mahon
B E
BE
Griffin
P M
PM
Mead
P S
PS
Tauxe
R V
RV
D001427:Bacterial Toxins / Q000096:biosynthesis; D004926:Escherichia coli / Q000378:metabolism / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000453:epidemiology* / Q000382:microbiology* / Q000517:prevention & control; D019453:Escherichia coli O157 / Q000472:pathogenicity; D006463:Hemolytic-Uremic Syndrome / Q000453:epidemiology* / Q000382:microbiology* / Q000517:prevention & control; D006801:Humans; D011159:Population Surveillance; D012307:Risk Factors; D022603:Shiga Toxins; D014481:United States / Q000453:epidemiology
D001427:Bacterial Toxins; D022603:Shiga Toxins